参考文献

• DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury. ACS Appl Mater Interfaces. 2024 Jul 19. (IF 8.7)(Mouse M-CSF)
• Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy. Adv Mater. 2024 Jul 18:e2406140. (IF 27.4)(Mouse CCL2)
• Lyssavirus matrix protein inhibits NLRP3 inflammasome assembly by binding to NLRP3. Cell Rep. 2024 Jul 9;43(7):114478. (IF 7.5)(Mouse GM-CSF)
• Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Sci Adv. 2024 Jun 28;10(26):eado6798. (IF11.7)(Mouse IL-4)
• EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.Thorac Cancer. 2023 Feb;14(5):450-461. (IF 2.9)
• Antagonizing apolipoprotein J chaperone promotes proteasomal degradation of mTOR and relieves hepatic lipid deposition. Hepatology. 2023 Oct 1;78(4):1182-1199. (IF 12.9)